Newsroom

Newsroomjsctek_6qxlvs2023-04-04T14:39:19+00:00

LATEST NEWS AND EVENTS

Meet our team at the SNNMI23

Join Alice at ASCO23

Meet us at the ISRT 2023

The Tackle Cancer Challenge is back!

The Third Edition of Radiotheranostics Today is out!

Meet us at the EAU 2023

Thank you for your support!

The 12th International Symposium in Cape Town

Doctor, will radiotheranostics make me radioactive?

The Michael Hofman Masterclass

EANM response to ASTRO’s framework for trainees

A major component to successfully establish radioligand therapy

Happy New Year !

European Commission approves Pluvicto™

Novel PET Agent to Identify Patients for Targeted Therapies

Quo Vadis, Teragnosis?

The Cary M. Adams Fund

Discover Our Youtube Channel

New PET Tracer Shows Promise for NENs

What are Radiotheranostics for Cancer Care?

Dr Acosta’s testimonial : A journey living with prostate cancer

EANM 2022

The Oncidium foundation is hiring!

36th Brazilian Congress of Nuclear Medicine

Novel radiopharmaceutical pair detects and treats melanoma

SNMMI 2002 Image of the Year

SNMMI Abstract of the Year 2022

6th Theranostics World Congress

SNMMI 2022 Annual Meeting

Theranostics in the Arab World

Tackle Cancer Challenge, A Huge Thank You!

Cu-64-SAR-Bombesin PET-CT imaging for metastatic breast cancer

Tackle Cancer Challenge: It’s a wrap!

May 30 – Webinar – PSMA PET/CT Beyond the Images

ANZSNM 2022 – Brisbane, Australia

8th International Symposium on Medical Radioisotopes

The Second Edition of Radiotheranostics Today is out!

Lu-177-PSMA-617 approved by FDA for prostate cancer patients

Novel Radioligand Proven Superior for Metastatic Prostate Cancer

Rare is Many

World NGO Day 2022

Today is the World Cancer Day

Estimate the anticipated benefit from Lutetium-177-DOTATATE

Theranostics: A Smart Bomb for Cancer

Encouraging Early Results for Prostate Cancer Screening

Warm and Hopeful Wishes 2022

Radiotheranostics Today by the Oncidium foundation

European Cancer Summit 2021

Get more insight from the NOBLE Registry Website

EANM 2021 – VIRTUAL

Q&A: How a new imaging tool helps to better stage prostate cancer

Scandium radionuclides for theranostic applications

2nd ICPO FORUM

Emirates International Virtual Conference in Nuclear Medicine

Patient Management with Lu-177–PSMA-617 in the Clinic

Health Policy Partnership Framework

PSMA Theranostics: Current Landscape and Future Outlook

The Rising Role of Radiotheranostics

Lu-177-PSMA-617A Added to Standard Therapy

Theranostic Approach in Breast Cancer

FDA for Lu-177-PSMA-617 for mCRPC treatment

Global Nuclear Medicine Market 2013-2025

Drugmakers push into radio pharmaceuticals

NOBLE: Tc-99m-iPSMA SPECT shows promising results

Asco 2021 justifies Novartis’s radioligand Vision

SNMMI 2021 goes virtual

Theranostics: Reimagining the standard of care

EANM position paper on the role of radiobiology in nuclear medicine

ANZSNM 2021 Live and Local

Travel cards could help radiopharma patients avoid delays

PSMA theranostic Lu-177-PSMA-617 approaches prime time in mCRPC

XXII Congreso Argentino de Medicina Nuclear – Virtual Edition

Noble Registry – iPSMA SPECT Imaging for Prostate Cancer

Doctor, What is Neuroendocrine Cancer?

How Nuclear Technology can Beat Cancer

Seeing Cancer Cells, Killing Cancer Cells

Evolving role of Ac-225-PSMA Radioligand Therapy in mCRPC

World Theranostics Day 2021!

How PRRT can Improve Care for Neuroendocrine Tumor Patients

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy

Real-world data analysis of efficacy and survival after Lu-177 PSMA

PSMA Lu-177 x Ac-225

What is in the pipeline for nuclear medicine, globally?

Oncidium foundation welcomes it’s Turkish Ambassador

Oncidium foundation is a corporate member of the SNMMI Value Initiative

Joint Radionuclide Therapy-Immunotherapy Approach Effective in Prostate Cancer Model

The Winter Newsletter is out!

World Cancer Day 2021

Hopeful 2021!

New Theranostic Approach reduces tumor volume and increases survival in NET’s study

Another achievement to bring Radiotheranostics forward

NET Patient Testimonial, how PRRT saved Tom’s life

Diagnostic accuracy of F-18-PSMA-1007-PET/CT imaging for prostate carcinoma

IPET 2020 – all you need to know about Theranostics

Radiopharmaceuticals Emerging as New Cancer Therapy

October Rose – Breast Cancer Awareness Month

EANM ’20 – Let’s talk Radiotheranostics!

Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020

First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients

IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals

CONNECT WITH US

[fts_twitter twitter_name=OncidiumFoundat tweets_count=4 cover_photo=yes stats_bar=no show_retweets=no show_replies=no]